What’s New Related to Drugs
Want to know what’s new on drugs from FDA? This page provides quick links to the latest on a variety…
FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer
On January 17, 2025, the Food and Drug Administration approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo, Inc.), a Trop-2-directed antibody and…
FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory acute graft versus host disease in pediatric patients
Listen to a soundcast of the 12.18.2024 FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory acute graft versus host disease in…
Pharmaceutical Science and Clinical Pharmacology Advisory Committee Roster
This page contains the Pharmaceutical Science and Clinical Pharmacology Advisory Committee roster, which lists the current members and the current…
Generic Drug Facilities, Sites and Organization Lists
Generic Drug Facilities, Sites and Organization Lists
Drug Development and Drug Interactions | Resources
Possible models for decision making, advisory committee meetings, presentations, preventable adverse reactions
Drug Interaction Presentations
Drug Interaction Presentations
Drug Development and Drug Interactions: Advisory Committee Meetings
Drug Development and Drug Interactions: Advisory Committee Meetings
McDonald’s abandons commitment to DEI in supply chain
The fast food giant said it will shift to conducting “more integrated discussions” with suppliers about inclusion.
UPDATED PUBLIC PARTICIPATION INFORMATION: January 10, 2025: Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement – 01/10/2025
January 10, 2025: Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement